The Bid & Ask

Quotations, Dispatches, and the Daily Tape

Friday, August 14, 2026

Subject of the day

PBH

Concerning the House

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally. It operates in two segments, North American OTC Healthcare and International OTC Healthcare. The company offers analgesic powders under the BC and Goody's brand; various diaper rash treatments and skin protectants for babies under the Boudreaux's Butt Paste brand name; sprays and lozenges to relieve sore throats and mouth pain under the Chloraseptic brand; eye care products that provide relief from redness and itchiness under the Clear Eyes brand name; at-home removal of common and plantar warts under the Compound W brand; and ear wax removal products under the Debrox brand name. It also provides dental guards, floss picks, interdental brushes, dental repair and kits, and tongue cleaners under the DenTek brand; motion sickness relief products under the Dramamine brand; enemas and other laxative products under the Fleet brand name; stomach upset remedies under the Gaviscon brand; cough drops under the Luden's brand; products for yeast infections in women under the Monistat brand name; lice and parasite treatments under the Nix name; feminine care products, including washes, cloths, and sprays under the Summer's Eve brand; products for dry eyes under the TheraTears brand; nasal saline sprays and washes under the Fess brand name; and oral rehydration products under the Hydralyte brand. It sells its products to mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.

United States · www.prestigebrands.com

The Long Run

FY 2011–2026 · 15 years

LineLatestCAGRTrend
Revenue$1.13B+9.0%
Gross profit$624.45M+10.5%
Operating income$309.41M+8.2%
Net income$209.34M+17.8%
Cash from ops$257.63M+10.0%
Quotation

$51.32

-0.95 (-1.8%)

52w hi$70.21
52w lo$45.44
Vol529.04K
As ofAug 13
The Verdict

Hold

Our score -0.10

Short-0.26
Medium-0.01
Long+0.01

computed 2026-08-13

By the Numbers

Prestige Consumer Healthcare Inc.

Healthcare · Drug Manufacturers - Specialty & Generic

Market cap$2.43B
Enterprise value$4.45B
Trailing P/E14.38x
Forward P/E10.10x
EV / EBITDA13.69x
P / S (ttm)
Profit margin15.6%
Return on equity9.1%
Revenue growth+6.5%
Earnings growth-35.8%
Debt / equity107.86
Risk Metrics
Beta vs SPX0.37
Corr SPX0.20
Annual vol29.8%
Annual ret-8.8%
Sharpe-0.29
Max DD-49.0%

Window: 504 trading days (504 obs)

Layer Breakdown
LayerRawContribution
Fundamental+0.14
Sector+0.12
Technical-0.12
Earnings+0.00
Sentiment+0.00

macro × 1.00 · 2026-08-13

Recent Sessions
DateOpenHighLowCloseVol
Aug 13$52.77$52.90$50.70$51.32529.04K
Aug 12$54.50$54.72$52.25$52.27645.80K
Aug 11$52.87$53.75$52.39$53.60516.80K
Aug 10$54.31$54.87$52.64$53.00625.20K
Aug 7$54.95$55.45$54.15$54.85597.70K